Literature DB >> 34850884

Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.

Hiroyuki Suetsugu1,2,3, Kwangwoo Kim4,5, Takuaki Yamamoto6, So-Young Bang7,8, Yuma Sakamoto9, Jung-Min Shin7, Nobuhiko Sugano10, Ji Soong Kim7, Masaya Mukai11, Yeon-Kyung Lee7, Koichiro Ohmura12, Dae Jin Park7, Daisuke Takahashi13, Ga-Young Ahn7, Kohei Karino14, Young-Chang Kwon8, Tomoya Miyamura15, Jihye Kim8, Junichi Nakamura16, Goro Motomura3, Takeshi Kuroda17, Hiroaki Niiro18, Takeshi Miyamoto19, Tsutomu Takeuchi20, Katsunori Ikari21, Koichi Amano22, Yoshifumi Tada23, Ken Yamaji24, Masato Shimizu25, Takashi Atsumi26, Taisuke Seki27, Yoshiya Tanaka28, Toshikazu Kubo29, Ryo Hisada30, Tomokazu Yoshioka31, Mihoko Yamazaki32, Tamon Kabata33, Tomomichi Kajino34, Yoichi Ohta35, Takahiro Okawa36, Yohei Naito37, Ayumi Kaneuji38, Yuji Yasunaga39, Kenji Ohzono40, Kohei Tomizuka2, Masaru Koido2,41, Koichi Matsuda42,43, Yukinori Okada44,45, Akari Suzuki46, Bong-Jo Kim47, Yuta Kochi48, Hye-Soon Lee7,8, Shiro Ikegawa1, Sang-Cheol Bae7,8, Chikashi Terao2,49,50.   

Abstract

Osteonecrosis of the femoral head (ONFH) involves necrosis of bone and bone marrow of the femoral head caused by ischemia with unknown etiology. Previous genetic studies on ONFH failed to produce consistent results, presumably because ONFH has various causes with different genetic backgrounds and the underlying diseases confounded the associations. Steroid-associated ONFH (S-ONFH) accounts for one-half of all ONFH, and systemic lupus erythematosus (SLE) is a representative disease underlying S-ONFH. We performed a genome-wide association study (GWAS) to identify genetic risk factors for S-ONFH in patients with SLE. We conducted a two-staged GWAS on 636 SLE patients with S-ONFH and 95 588 non-SLE controls. Among the novel loci identified, we determined S-ONFH-specific loci by comparing allele frequencies between SLE patients without S-ONFH and non-SLE controls. We also used Korean datasets comprising 148 S-ONFH cases and 37 015 controls to assess overall significance. We evaluated the functional annotations of significant variants by in silico analyses. The Japanese GWAS identified 4 significant loci together with 12 known SLE susceptibility loci. The four significant variants showed comparable effect sizes on S-ONFH compared with SLE controls and non-SLE controls. Three of the four loci, MIR4293/MIR1265 [odds ratio (OR) = 1.99, P-value = 1.1 × 10-9)], TRIM49/NAALAD2 (OR = 1.65, P-value = 4.8 × 10-8) and MYO16 (OR = 3.91, P-value = 4.9 × 10-10), showed significant associations in the meta-analysis with Korean datasets. Bioinformatics analyses identified MIR4293, NAALAD2 and MYO16 as candidate causal genes. MIR4293 regulates a PPARG-related adipogenesis pathway relevant to S-ONFH. We identified three novel susceptibility loci for S-ONFH in SLE.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34850884      PMCID: PMC8976424          DOI: 10.1093/hmg/ddab306

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  53 in total

1.  Incidence of nontraumatic osteonecrosis of the femoral head in the Japanese population.

Authors:  Ryosuke Yamaguchi; Takuaki Yamamoto; Goro Motomura; Satoshi Ikemura; Yukihide Iwamoto
Journal:  Arthritis Rheum       Date:  2011-10

Review 2.  Nontraumatic necrosis of bone (osteonecrosis).

Authors:  H J Mankin
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

3.  The role of lncRNA RP11-154D6 in steroid-induced osteonecrosis of the femoral head through BMSC regulation.

Authors:  Shuai Xiang; Zeng Li; Xisheng Weng
Journal:  J Cell Biochem       Date:  2019-06-12       Impact factor: 4.429

4.  PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes.

Authors:  Shuji Akizuki; Kazuyoshi Ishigaki; Yuta Kochi; Sze-Ming Law; Keitaro Matsuo; Koichiro Ohmura; Akari Suzuki; Manabu Nakayama; Yusuke Iizuka; Haruhiko Koseki; Osamu Ohara; Jun Hirata; Yoichiro Kamatani; Fumihiko Matsuda; Takayuki Sumida; Kazuhiko Yamamoto; Yukinori Okada; Tsuneyo Mimori; Chikashi Terao
Journal:  Ann Rheum Dis       Date:  2019-01-24       Impact factor: 19.103

5.  Genetic variation in the coagulation factor V gene and risk of femoral head osteonecrosis.

Authors:  Tae-Ho Kim; Seung-Hoon Baek; Jeong Ok Lim; Sang-Han Lee; Shin-Yoon Kim
Journal:  Mol Med Rep       Date:  2015-06-25       Impact factor: 2.952

6.  Association of SREBP2 gene polymorphisms with the risk of osteonecrosis of the femoral head relates to gene expression and lipid metabolism disorders.

Authors:  Yang Song; Zhenwu Du; Bingpeng Chen; Ming Ren; Qiwei Yang; Yujie Sui; Qingyu Wang; Ao Wang; Haiyue Zhao; Yanguo Qin; Guizhen Zhang
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

7.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

8.  Functional mapping and annotation of genetic associations with FUMA.

Authors:  Kyoko Watanabe; Erdogan Taskesen; Arjen van Bochoven; Danielle Posthuma
Journal:  Nat Commun       Date:  2017-11-28       Impact factor: 14.919

9.  FINEMAP: efficient variable selection using summary data from genome-wide association studies.

Authors:  Christian Benner; Chris C A Spencer; Aki S Havulinna; Veikko Salomaa; Samuli Ripatti; Matti Pirinen
Journal:  Bioinformatics       Date:  2016-01-14       Impact factor: 6.937

10.  Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head.

Authors:  Yuma Sakamoto; Takuaki Yamamoto; Nobuhiko Sugano; Daisuke Takahashi; Toshiyuki Watanabe; Takashi Atsumi; Junichi Nakamura; Yukiharu Hasegawa; Koichi Akashi; Ichiei Narita; Takeshi Miyamoto; Tsutomu Takeuchi; Katsunori Ikari; Koichi Amano; Atsuhiro Fujie; Toshikazu Kubo; Yoshifumi Tada; Ayumi Kaneuji; Hiroaki Nakamura; Tomoya Miyamura; Tamon Kabata; Ken Yamaji; Takahiro Okawa; Akihiro Sudo; Kenji Ohzono; Yoshiya Tanaka; Yuji Yasunaga; Shuichi Matsuda; Yuuki Imai; Masato Akiyama; Michiaki Kubo; Yoichiro Kamatani; Yukihide Iwamoto; Shiro Ikegawa
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.